Safety and Efficacy of Changing to DuoTrav in Patients Uncontrolled on Timolol

Completed · Phase 4

Conditions studied: Glaucoma

In brief

The purpose of this study was to assess the safety and intraocular pressure (IOP)-lowering efficacy of changing to DuoTrav® from prior timolol 0.5% monotherapy in participants with open-angle glaucoma or ocular hypertension.

Key facts

Study ID
NCT01336569
Run by
Alcon Research
People needed
50
Starts
2011-02-01
Expected to finish
2012-03-01
Last updated by the study team
2013-07-08

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.